Loading…

Developmental effects of SSRIs: lessons learned from animal studies

Selective serotonin reuptake inhibitors (SSRIs) are utilized in the treatment of depression in pregnant and lactating women. SSRIs may be passed to the fetus through the placenta and the neonate through breastfeeding, potentially exposing them to SSRIs during peri‐ and postnatal development. However...

Full description

Saved in:
Bibliographic Details
Published in:International journal of developmental neuroscience 2007-10, Vol.25 (6), p.341-347
Main Authors: Borue, Xenia, Chen, John, Condron, Barry G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5093-1eba5831bd5de0234e44487db8872a5dc377bfded3d4b1563c106ae4fac5f6f23
cites cdi_FETCH-LOGICAL-c5093-1eba5831bd5de0234e44487db8872a5dc377bfded3d4b1563c106ae4fac5f6f23
container_end_page 347
container_issue 6
container_start_page 341
container_title International journal of developmental neuroscience
container_volume 25
creator Borue, Xenia
Chen, John
Condron, Barry G.
description Selective serotonin reuptake inhibitors (SSRIs) are utilized in the treatment of depression in pregnant and lactating women. SSRIs may be passed to the fetus through the placenta and the neonate through breastfeeding, potentially exposing them to SSRIs during peri‐ and postnatal development. However, the long‐term effects of this SSRI exposure are still largely unknown. The simplicity and genetic amenability of model organisms provides a critical experimental advantage compared to studies with humans. This review will assess the current research done in animals that sheds light on the role of serotonin during development and the possible effects of SSRIs. Experimental studies in rodents show that administration of SSRIs during a key developmental window creates changes in brain circuitry and maladaptive behaviors that persist into adulthood. Similar changes result from the inhibition of the serotonin transporter or monoamine oxidase, implicating these two regulators of serotonin signaling in developmental changes. Understanding the role of serotonin in brain development is critical to identifying the possible effects of SSRI exposure.
doi_str_mv 10.1016/j.ijdevneu.2007.06.003
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2277509</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68494446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5093-1eba5831bd5de0234e44487db8872a5dc377bfded3d4b1563c106ae4fac5f6f23</originalsourceid><addsrcrecordid>eNqNkV1r2zAUhkXZWNNsf6H4and2j6wvpxeFkaRbQmmhXcfuhGwddQ62lVpxRv_9ZJJ9XW1XB6TnvHrES8g5hYwClRebrN5Y3Hc4ZDmAykBmAOyETGihWMoV__qKTEAxmQrFi1NyFsIGAIQA_oacUqVAspmckPkC99j4bYvdzjQJOofVLiTeJQ8P96twmTQYgu9CnKbv0Cau921iurqNdNgNtsbwlrx2pgn47jin5PF6-Xn-Kb25-7iaf7hJKwEzllIsjSgYLa2wCDnjyDkvlC2LQuVG2IopVTqLllleUiFZRUEa5M5UwkmXsym5OuRuh7JFW0Xl3jR620eZ_kV7U-u_b7r6m37ye53nSo0KU_L-GND75wHDTrd1qLBpTId-CFoWfBad5D_BHDgtBNAIygNY9T6EHt0vGwp6LEpv9M-i9FiUBqljUXHx_M-__F47NhOB1QH4Xjf48p-xer24Xa_Wi-WX2-XjeA5yfOwHVb6qKg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20418501</pqid></control><display><type>article</type><title>Developmental effects of SSRIs: lessons learned from animal studies</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Borue, Xenia ; Chen, John ; Condron, Barry G.</creator><creatorcontrib>Borue, Xenia ; Chen, John ; Condron, Barry G.</creatorcontrib><description>Selective serotonin reuptake inhibitors (SSRIs) are utilized in the treatment of depression in pregnant and lactating women. SSRIs may be passed to the fetus through the placenta and the neonate through breastfeeding, potentially exposing them to SSRIs during peri‐ and postnatal development. However, the long‐term effects of this SSRI exposure are still largely unknown. The simplicity and genetic amenability of model organisms provides a critical experimental advantage compared to studies with humans. This review will assess the current research done in animals that sheds light on the role of serotonin during development and the possible effects of SSRIs. Experimental studies in rodents show that administration of SSRIs during a key developmental window creates changes in brain circuitry and maladaptive behaviors that persist into adulthood. Similar changes result from the inhibition of the serotonin transporter or monoamine oxidase, implicating these two regulators of serotonin signaling in developmental changes. Understanding the role of serotonin in brain development is critical to identifying the possible effects of SSRI exposure.</description><identifier>ISSN: 0736-5748</identifier><identifier>EISSN: 1873-474X</identifier><identifier>DOI: 10.1016/j.ijdevneu.2007.06.003</identifier><identifier>PMID: 17706396</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Brain - drug effects ; Brain - embryology ; Brain - physiopathology ; CNS development ; Disease Models, Animal ; Female ; Humans ; Monoamine Oxidase - drug effects ; Monoamine Oxidase - metabolism ; Neurotransmitter ; Pregnancy ; Prenatal Exposure Delayed Effects - chemically induced ; Prenatal Exposure Delayed Effects - metabolism ; Prenatal Exposure Delayed Effects - physiopathology ; Serotonin ; Serotonin - metabolism ; Serotonin - physiology ; Serotonin Plasma Membrane Transport Proteins - drug effects ; Serotonin Plasma Membrane Transport Proteins - metabolism ; Serotonin Uptake Inhibitors - adverse effects ; Synaptic Transmission - drug effects ; Synaptic Transmission - physiology</subject><ispartof>International journal of developmental neuroscience, 2007-10, Vol.25 (6), p.341-347</ispartof><rights>2007 ISDN</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5093-1eba5831bd5de0234e44487db8872a5dc377bfded3d4b1563c106ae4fac5f6f23</citedby><cites>FETCH-LOGICAL-c5093-1eba5831bd5de0234e44487db8872a5dc377bfded3d4b1563c106ae4fac5f6f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17706396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Borue, Xenia</creatorcontrib><creatorcontrib>Chen, John</creatorcontrib><creatorcontrib>Condron, Barry G.</creatorcontrib><title>Developmental effects of SSRIs: lessons learned from animal studies</title><title>International journal of developmental neuroscience</title><addtitle>Int J Dev Neurosci</addtitle><description>Selective serotonin reuptake inhibitors (SSRIs) are utilized in the treatment of depression in pregnant and lactating women. SSRIs may be passed to the fetus through the placenta and the neonate through breastfeeding, potentially exposing them to SSRIs during peri‐ and postnatal development. However, the long‐term effects of this SSRI exposure are still largely unknown. The simplicity and genetic amenability of model organisms provides a critical experimental advantage compared to studies with humans. This review will assess the current research done in animals that sheds light on the role of serotonin during development and the possible effects of SSRIs. Experimental studies in rodents show that administration of SSRIs during a key developmental window creates changes in brain circuitry and maladaptive behaviors that persist into adulthood. Similar changes result from the inhibition of the serotonin transporter or monoamine oxidase, implicating these two regulators of serotonin signaling in developmental changes. Understanding the role of serotonin in brain development is critical to identifying the possible effects of SSRI exposure.</description><subject>Animals</subject><subject>Brain - drug effects</subject><subject>Brain - embryology</subject><subject>Brain - physiopathology</subject><subject>CNS development</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Humans</subject><subject>Monoamine Oxidase - drug effects</subject><subject>Monoamine Oxidase - metabolism</subject><subject>Neurotransmitter</subject><subject>Pregnancy</subject><subject>Prenatal Exposure Delayed Effects - chemically induced</subject><subject>Prenatal Exposure Delayed Effects - metabolism</subject><subject>Prenatal Exposure Delayed Effects - physiopathology</subject><subject>Serotonin</subject><subject>Serotonin - metabolism</subject><subject>Serotonin - physiology</subject><subject>Serotonin Plasma Membrane Transport Proteins - drug effects</subject><subject>Serotonin Plasma Membrane Transport Proteins - metabolism</subject><subject>Serotonin Uptake Inhibitors - adverse effects</subject><subject>Synaptic Transmission - drug effects</subject><subject>Synaptic Transmission - physiology</subject><issn>0736-5748</issn><issn>1873-474X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNkV1r2zAUhkXZWNNsf6H4and2j6wvpxeFkaRbQmmhXcfuhGwddQ62lVpxRv_9ZJJ9XW1XB6TnvHrES8g5hYwClRebrN5Y3Hc4ZDmAykBmAOyETGihWMoV__qKTEAxmQrFi1NyFsIGAIQA_oacUqVAspmckPkC99j4bYvdzjQJOofVLiTeJQ8P96twmTQYgu9CnKbv0Cau921iurqNdNgNtsbwlrx2pgn47jin5PF6-Xn-Kb25-7iaf7hJKwEzllIsjSgYLa2wCDnjyDkvlC2LQuVG2IopVTqLllleUiFZRUEa5M5UwkmXsym5OuRuh7JFW0Xl3jR620eZ_kV7U-u_b7r6m37ye53nSo0KU_L-GND75wHDTrd1qLBpTId-CFoWfBad5D_BHDgtBNAIygNY9T6EHt0vGwp6LEpv9M-i9FiUBqljUXHx_M-__F47NhOB1QH4Xjf48p-xer24Xa_Wi-WX2-XjeA5yfOwHVb6qKg</recordid><startdate>200710</startdate><enddate>200710</enddate><creator>Borue, Xenia</creator><creator>Chen, John</creator><creator>Condron, Barry G.</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200710</creationdate><title>Developmental effects of SSRIs: lessons learned from animal studies</title><author>Borue, Xenia ; Chen, John ; Condron, Barry G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5093-1eba5831bd5de0234e44487db8872a5dc377bfded3d4b1563c106ae4fac5f6f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Brain - drug effects</topic><topic>Brain - embryology</topic><topic>Brain - physiopathology</topic><topic>CNS development</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Humans</topic><topic>Monoamine Oxidase - drug effects</topic><topic>Monoamine Oxidase - metabolism</topic><topic>Neurotransmitter</topic><topic>Pregnancy</topic><topic>Prenatal Exposure Delayed Effects - chemically induced</topic><topic>Prenatal Exposure Delayed Effects - metabolism</topic><topic>Prenatal Exposure Delayed Effects - physiopathology</topic><topic>Serotonin</topic><topic>Serotonin - metabolism</topic><topic>Serotonin - physiology</topic><topic>Serotonin Plasma Membrane Transport Proteins - drug effects</topic><topic>Serotonin Plasma Membrane Transport Proteins - metabolism</topic><topic>Serotonin Uptake Inhibitors - adverse effects</topic><topic>Synaptic Transmission - drug effects</topic><topic>Synaptic Transmission - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Borue, Xenia</creatorcontrib><creatorcontrib>Chen, John</creatorcontrib><creatorcontrib>Condron, Barry G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of developmental neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Borue, Xenia</au><au>Chen, John</au><au>Condron, Barry G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Developmental effects of SSRIs: lessons learned from animal studies</atitle><jtitle>International journal of developmental neuroscience</jtitle><addtitle>Int J Dev Neurosci</addtitle><date>2007-10</date><risdate>2007</risdate><volume>25</volume><issue>6</issue><spage>341</spage><epage>347</epage><pages>341-347</pages><issn>0736-5748</issn><eissn>1873-474X</eissn><abstract>Selective serotonin reuptake inhibitors (SSRIs) are utilized in the treatment of depression in pregnant and lactating women. SSRIs may be passed to the fetus through the placenta and the neonate through breastfeeding, potentially exposing them to SSRIs during peri‐ and postnatal development. However, the long‐term effects of this SSRI exposure are still largely unknown. The simplicity and genetic amenability of model organisms provides a critical experimental advantage compared to studies with humans. This review will assess the current research done in animals that sheds light on the role of serotonin during development and the possible effects of SSRIs. Experimental studies in rodents show that administration of SSRIs during a key developmental window creates changes in brain circuitry and maladaptive behaviors that persist into adulthood. Similar changes result from the inhibition of the serotonin transporter or monoamine oxidase, implicating these two regulators of serotonin signaling in developmental changes. Understanding the role of serotonin in brain development is critical to identifying the possible effects of SSRI exposure.</abstract><cop>United States</cop><pmid>17706396</pmid><doi>10.1016/j.ijdevneu.2007.06.003</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0736-5748
ispartof International journal of developmental neuroscience, 2007-10, Vol.25 (6), p.341-347
issn 0736-5748
1873-474X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2277509
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Brain - drug effects
Brain - embryology
Brain - physiopathology
CNS development
Disease Models, Animal
Female
Humans
Monoamine Oxidase - drug effects
Monoamine Oxidase - metabolism
Neurotransmitter
Pregnancy
Prenatal Exposure Delayed Effects - chemically induced
Prenatal Exposure Delayed Effects - metabolism
Prenatal Exposure Delayed Effects - physiopathology
Serotonin
Serotonin - metabolism
Serotonin - physiology
Serotonin Plasma Membrane Transport Proteins - drug effects
Serotonin Plasma Membrane Transport Proteins - metabolism
Serotonin Uptake Inhibitors - adverse effects
Synaptic Transmission - drug effects
Synaptic Transmission - physiology
title Developmental effects of SSRIs: lessons learned from animal studies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T21%3A50%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Developmental%20effects%20of%20SSRIs:%20lessons%20learned%20from%20animal%20studies&rft.jtitle=International%20journal%20of%20developmental%20neuroscience&rft.au=Borue,%20Xenia&rft.date=2007-10&rft.volume=25&rft.issue=6&rft.spage=341&rft.epage=347&rft.pages=341-347&rft.issn=0736-5748&rft.eissn=1873-474X&rft_id=info:doi/10.1016/j.ijdevneu.2007.06.003&rft_dat=%3Cproquest_pubme%3E68494446%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5093-1eba5831bd5de0234e44487db8872a5dc377bfded3d4b1563c106ae4fac5f6f23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20418501&rft_id=info:pmid/17706396&rfr_iscdi=true